Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.80
Delayed Data
As of Dec 02
 -0.0205 / -2.50%
Today’s Change
0.72
Today|||52-Week Range
2.64
-17.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash2.2M803.0K2.2M2.1M
 
 
 
 
 
Short Term Investment Cash-891.0K-1.4M1.4M-41.0K
 
 
 
 
 
Cash & Short Term Investments44.0M18.2M16.1M8.9M
 
 
 
 
 
 
ReceivablesReceivables0.000.00--0.00--
 
InventoriesInventories453.0K0.00--1.3M
 
 
 
 
Current AssetsOther Current Assets322.0K358.0K399.0K335.0K
 
 
 
 
 
Current Assets44.7M18.6M16.5M10.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross15.5M16.4M16.9M17.2M
 
 
 
 
 
Depreciation-3.7M-4.3M-5.0M-5.9M
 
 
 
 
 
Intangible Assets1.0M1.1M861.0K862.0K
 
 
 
 
 
Other Assets1.1M1.2M995.0K996.0K
 
 
 
 
 
Total Assets57.7M31.9M29.4M22.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.2M1.3M2.1M1.2M
 
 
 
 
 
Short Term Debt7.1M33.0K22.0K1.0K
 
 
 
 
 
Accrued Expenses1.3M850.0K527.0K990.0K
 
 
 
 
 
Other Current Liabilities1.3M850.0K527.0K990.0K
 
 
 
 
 
Other Liabilities12.6M2.5M4.4M2.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt55.0K23.0K0.000.00
 
 
 
Other Liabilities295.0K14.0K0.000.00
 
 
 
Total Liabilities13.0M2.6M4.4M2.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity44.7M29.3M25.0M20.4M
 
 
 
 
 
Total Shareholder Equity44.7M29.3M25.0M20.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding13.9M14.1M17.0M20.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.